Other MST family members have been implicated in prostate cancer, including MST1 and MST4, while MST1 levels were found to decline with disease progression20, MST4 expression levels were positively correlated with the tumorigenicity of prostate cancer21. This evidence concerns the gene STK26 and prostate cancer.